Dechra Pharmaceuticals - Overview

Dechra Pharmaceuticals, founded in 1997 following a management buy-out from Lloyds Chemists, develops prescription only veterinary medicines for dogs, cats and horses. Most of its projects involve adapting treatments, currently used by humans, for the animal market. Expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. It listed in London in 2000.

Registrars:

Key Personnel

CEO: Ian Page
CFO: Paul Sandland
Non-Executive Director: Geeta Gopalan, John Shipsey
Non-Executive Chairman: Alison Platt
Senior Independent Director: Lawson Macartney
Independent Non-Executive Director: Lisa Bright

Contact Details

Address: 24 Cheshire Avenue, Cheshire Business Park, Lostock Gralam, Northwich, United Kingdom
Phone: +44 (0) 160 681 4730
Fax: +44 (0) 160 681 4731
Website: http://www.dechra.com/
Email:

Listings

ISIN: GB0009633180